Alector (NASDAQ:ALEC – Get Free Report) is expected to be releasing its Q2 2026 results after the market closes on Thursday, August 6th. Analysts expect Alector to announce earnings of ($0.2213) per share and revenue of $1.4280 million for the quarter. Individuals can find conference call details on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Thursday, August 13, 2026 at 4:30 PM ET.
Alector (NASDAQ:ALEC – Get Free Report) last announced its quarterly earnings results on Thursday, May 7th. The company reported ($0.21) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.08. Alector had a negative return on equity of 295.17% and a negative net margin of 680.83%.The company had revenue of $1.05 million during the quarter, compared to the consensus estimate of $9.67 million. On average, analysts expect Alector to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Alector Trading Up 2.0%
ALEC opened at $1.54 on Wednesday. The company has a debt-to-equity ratio of 0.80, a quick ratio of 5.25 and a current ratio of 5.25. Alector has a one year low of $1.09 and a one year high of $3.40. The company has a market cap of $170.99 million, a P/E ratio of -1.29 and a beta of 0.60. The business’s 50-day simple moving average is $1.71 and its 200-day simple moving average is $2.01.
Analyst Upgrades and Downgrades
Check Out Our Latest Research Report on ALEC
Insider Activity
In other Alector news, CFO Neil Lindsay Berkley sold 19,360 shares of Alector stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $1.97, for a total value of $38,139.20. Following the transaction, the chief financial officer directly owned 379,900 shares in the company, valued at approximately $748,403. This trade represents a 4.85% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Arnon Rosenthal sold 87,216 shares of Alector stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $1.97, for a total value of $171,815.52. Following the completion of the transaction, the chief executive officer owned 2,367,206 shares in the company, valued at $4,663,395.82. This trade represents a 3.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 115,760 shares of company stock worth $227,734 in the last 90 days. 8.30% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Alector
Hedge funds have recently modified their holdings of the stock. Prudential Financial Inc. acquired a new position in Alector in the 2nd quarter valued at $30,000. Virtu Financial LLC acquired a new stake in shares of Alector in the 4th quarter worth $34,000. Dynamic Technology Lab Private Ltd acquired a new stake in shares of Alector in the 4th quarter worth $40,000. Oxford Asset Management LLP purchased a new stake in shares of Alector in the fourth quarter valued at about $67,000. Finally, Quadrature Capital Ltd purchased a new stake in shares of Alector in the fourth quarter valued at about $97,000. 85.83% of the stock is owned by institutional investors and hedge funds.
Alector Company Profile
Alector is a clinical-stage biotechnology company headquartered in South San Francisco, California. Founded in 2013, the company is focused on discovering and developing immuno-neurology therapies that target the innate immune system to treat a range of neurodegenerative disorders. Alector’s approach aims to harness the body’s natural defense mechanisms to clear pathological proteins and restore neuronal function in conditions such as Alzheimer’s disease and frontotemporal dementia.
The company’s pipeline includes multiple product candidates in both preclinical and clinical stages, with lead programs AL001 and AL002 advancing in frontotemporal dementia and Alzheimer’s disease studies.
Featured Stories
- Five stocks we like better than Alector
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Receive News & Ratings for Alector Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alector and related companies with MarketBeat.com's FREE daily email newsletter.
